RenovoRx
RNXT
27 hedge funds and large institutions have $9.98M invested in RenovoRx in 2025 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 4 closing their positions.
663% more capital invested
Capital invested by funds: $1.31M → $9.98M (+$8.67M)
250% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 2
225% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 4
50% more funds holding
Funds holding: 18 → 27 (+9)
24.14% more ownership
Funds ownership: 4.22% → 28.36% (+24%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$4.04M |
| 2 |
AIC
AWM Investment Company
New York
|
+$2.66M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.4M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$801K |
| 5 |
BL
Bleichroeder LP
New York
|
+$582K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$99.1K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$48.7K |
| 3 |
Renaissance Technologies
New York
|
-$43.3K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$15.1K |
| 5 |
Citigroup
New York
|
-$495 |
RNXT Hedge Fund Activity: Q1 2025 in Review
27 of the 7,466 institutional investors tracked by Wall St. Rank reported a position in RenovoRx (RNXT) for Q1 2025, worth a combined $9.98M — up 663% from $1.31M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new RNXT positions and 4 closed out — a net gain of 9 holders — while 7 added to existing stakes and 2 trimmed.
The largest buyer was AIGH Capital Management, opening a new position worth an estimated $4.04M. The largest seller was Millennium Management, exiting entirely with an estimated $99.1K sold.
- 27 institutional investors held RenovoRx (RNXT) as of Q1 2025, up from 18 in Q4 2024.
- Funds reported $9.98M of RenovoRx stock for Q1 2025, up 663% quarter-over-quarter.
- 13 funds opened new RenovoRx positions in Q1 2025 and 4 closed out, a net change of +9 holders.
- The largest RenovoRx buyer in Q1 2025 was AIGH Capital Management, an estimated $4.04M added.
- The largest RenovoRx seller in Q1 2025 was Millennium Management, an estimated $99.1K sold.
Based on aggregated 13F filings for Q1 2025.